$1.79-0.07 (-3.75%)
News25/Ratings0
Price$1.79-0.07 (-3.49%)
2026-01-202026-04-23
News · 26 weeks42+150%
2025-10-262026-04-19
Mix2290d
- Market14(64%)
- Insider5(23%)
- SEC Filings3(14%)
Latest news
25 items- INSIDERSEC Form 4 filed by Tsai Chun-Jung4 - Ainos, Inc. (0001014763) (Issuer)
- INSIDERSEC Form 4 filed by Tsai Chun-Hsien4 - Ainos, Inc. (0001014763) (Issuer)
- INSIDERSEC Form 4 filed by Lee Ting-Chuan4 - Ainos, Inc. (0001014763) (Issuer)
- NEWSVASRO: Ainos Expands Smell AI from Industrials into Healthcare Infrastructure, Reinforcing AI Infrastructure Positioning and Multi-Vertical Scalability2026 Identified as a Key Scale-Up Phase with Expanding Market Verticals and Accelerating Data Flywheel HOUSTON, TX / ACCESS Newswire / April 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today highlighted the continued expansion of its Smell AI deployments, powered by AI Nose, across semiconductor, robotics, and healthcare infrastructure, highlighted by recent third-party research published by VASRO GmbH. The report underscores Smell AI's progression from isolated sensing applications to scalable multi-domain AI perception platform and identifies 2026 as a key scale-up year as Ainos moves toward deployment and repeatable revenue generation.The report highlights growing visibility into S
- INSIDERSEC Form 4 filed by Ase Test, Inc.4 - Ainos, Inc. (0001014763) (Issuer)
- NEWSAinos, MacKay Memorial Hospital and Topco Scientific Partner to Advance Smell AI Deployment in High-Risk Hospital EnvironmentsExpands AI Nose platform from industrial safety into clinical infrastructureHOUSTON, TX / ACCESS Newswire / April 8, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) today announced a partnership with MacKay Memorial Hospital and Topco Scientific Co., Ltd. to deploy its AI Nose technology across high-risk hospital environments. The collaboration aims to expand Ainos' Smell AI platform from industrial and environmental safety into healthcare infrastructure, marking a key step in its commercialization roadmap.Focused Deployment Across Four Core High-Risk Hospital EnvironmentsThe initial deployment, beginning in April 2026, focuses on environmental monitoring and safety across four critical hospi
- NEWSVASRO Research Highlights Ainos' Smell AI Commercial Progress and 2026 Deployment MomentumReport highlights transition to deployment-driven growth, with visible semiconductor rollout and early customer-backed revenueSmell AI, powered by AI Nose, is emerging as a new AI perception layer, supported by accelerating commercialization and expanding industrial adoptionHOUSTON, TX / ACCESS Newswire / April 1, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today highlighted findings from a research report published by VASRO GmbH, which points to accelerating commercial progress of "Smell AI" powered by AI Nose, and improving visibility into 2026 deployments.The report notes that Ainos has moved beyond early validation and is now entering a more execution-driven
- SECSEC Form 10-K filed by Ainos Inc.10-K - Ainos, Inc. (0001014763) (Filer)
- SECAinos Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Ainos, Inc. (0001014763) (Filer)
- NEWSAinos Reports Full Year 2025 Financial Results and Highlights Commercial Momentum Entering 2026AI Nose drove 499% revenue growth in 2025, with gross margin turning positive to 82.9%2025 partnerships now driving scaled AI Nose deployments in 2026, supported by disciplined financingHOUSTON, TX / ACCESS Newswire / March 30, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today reported financial results for the year ended December 31, 2025 and outlined commercialization momentum entering 2026.During 2025, Ainos expanded its industrial ecosystem of AI Nose platform across semiconductor, smart factory, robotics, and industrial AI environments, establishing the foundation for deployment-driven growth. AI Nose deployments combine hardware sensing with recurring soft
- NEWSThe Wall Street Journal Highlights Emerging "Smell AI" - Ainos Advances Commercial Deployment in Semiconductor EnvironmentsAs AI expands beyond vision and language, Ainos advances commercial deployment of AI Nose in industrial environments-positioning the Company at the forefront of this emerging categoryHOUSTON, TX / ACCESS Newswire / March 19, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform digitizing scent as a native data language for artificial intelligence, today highlighted its inclusion in The Wall Street Journal article "The E-Nose Knows: AI Learns to Smell," which underscores the emergence of AI capable of sensing and interpreting smell-expanding beyond traditional modalities such as vision, speech, and language.The article describes how AI-powered electr
- NEWSWater Tower Research Highlights Ainos' Scaling Momentum Across Semiconductor Value ChainAI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in semiconductor manufacturing environmentsRecurring revenue visibility strengthens as AI Nose deployments scale across the semiconductor ecosystemHOUSTON, TX / ACCESS Newswire / March 12, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that Water Tower Research ("WTR") has published a report highlighting Ainos' accelerating momentum across the semiconductor value chain as its AI Nose platform gains traction in both front-end wafer fabrication and back-end
- NEWSAinos Expands AI Nose Validation in Front-End Wafer Fabs with 200 Targeted Deployments in Q1 2026Company affirms execution milestones, subscription activation roadmap, and long-term infrastructure vision remain unchanged despite market volatilityHOUSTON, TEXAS / ACCESS Newswire / March 9, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced continued validation testing of its AI Nose platform within advanced semiconductor front-end wafer fabrication environments.As part of this qualification phase, Ainos plans to install approximately 200 AI Nose systems across targeted front-end facilities in the first quarter of 2026 for technical validation. These deployments would set the foundation for commercial integration in front-end wafer fabrication facili
- NEWSAinos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue OpportunityHOUSTON, TEXAS / ACCESS Newswire / March 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today issued the following letter from Chairman, President and Chief Executive Officer Eddy Tsai to shareholders, outlining the recurring revenue opportunity under the phased deployment framework of up to 20,000 AI Nose systems, and ongoing validation within advanced front-end semiconductor fabrication environments.To Our Shareholders,I'm proud to share that the AI Nose platform is transitioning from validation-stage pilots into structured industrial deployment.The confirmed initial order of 1,400 AI Nose systems activates recurring subscription revenue under a three-year ser
- NEWSAinos Activates Industrial-Scale Deployment Roadmap of Up to 20,000 Units, Advancing AI Infrastructure Integration in Semiconductor Production EnvironmentsHOUSTON, TEXAS / ACCESS Newswire / February 23, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced the activation of a phased industrial deployment roadmap under a strategic framework that contemplates the installation of up to 20,000 AI Nose units within semiconductor manufacturing environments.Phased Expansion Framework within Back-end Semiconductor EnvironmentsThe framework under a Memorandum of Understanding with ASE Technology Holding Co., Ltd. ("ASEH") outlines a multi-phase expansion strategy designed to integrate digital olfaction, powered by the AI Nose platform, into ASEH's semiconductor packaging and testing facilities.Ainos is executing the
- NEWSAinos Reports Statistically Significant Interim Efficacy Results from VELDONA Clinical Trial in Feline Chronic Gingivostomatitis (FCGS)Open-Label Study Demonstrates Durable Reduction in Oral Inflammation with Favorable Tolerability Profile at Interim AnalysisHOUSTON, TEXAS / ACCESS Newswire / February 17, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced interim results from its ongoing open-label, multi-dose clinical trial evaluating VELDONA, a low-dose oral interferon alpha formulation, for the treatment of Feline Chronic Gingivostomatitis (FCGS), a severe, chronic inflammatory oral disease in companion animals.The study is designed to enroll 12 client-owned cats diagnosed with FCGS
- SECSEC Form S-8 filed by Ainos Inc.S-8 - Ainos, Inc. (0001014763) (Filer)
- NEWSAinos Initiates Live AI Nose Deployments within Semiconductor Manufacturing EnvironmentsBack-end semiconductor deployments begin under initial customer orderFront-end semiconductor pilots advance across targeted environmentsHOUSTON, TEXAS / ACCESS Newswire / February 9, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced the start of AI Nose deployments tied to its first $2.1 million order from a semiconductor back-end customer, marking the Company's transition from preparation into operation.During the second half of 2025, Ainos carried out deployment readiness preparations. This groundwork positioned the AI Nose platform for live environm
- NEWSWater Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech ExpansionAI Nose integration positions robotics application as a scalable growth engineMirle partnership expands SmellTech robotics into industrial environmentsHOUSTON, TEXAS / ACCESS Newswire / February 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that Water Tower Research ("WTR") has published a report highlighting Ainos' expanding robotics opportunity and its strategy to scale the AI Nose platform across industrial and robotic applications, following the partnership with Mirle Automation Corporation ("Mirle").Key Highlights from the Report:Mirle Part
- NEWSWater Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value CreationAI Nose advances through a dual-engine architecture, enabling scalable deploymentsIndustrial and semiconductor deployments broaden Ainos' commercial footprintRobotics momentum accelerates data flywheel growth and commercial scale-up in 2026HOUSTON, TEXAS / ACCESS Newswire / February 4, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that Water Tower Research ("WTR") has published a report highlighting Ainos' SmellTech expansion, its value-creation strategy supported by a dual-engine architecture, and priorities for scaled execution in 2026. The repor
- NEWSAinos and Mirle Automation Partner to Bring Scent Intelligence to Robots and Quadruped RobotsAI Nose introduces scent as a machine-readable signal for robotic perceptionPartnership targets real-world deployment in mobile and quadruped robotic platformsHOUSTON, TEXAS / ACCESS Newswire / February 2, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced a technology partnership with Mirle Automation Corporation to integrate Ainos' AI Nose platform into robots and quadruped robots, enabling machines to sense and interpret environmental signals through scent.Robots increasingly rely on vision and audio to operate in physical environments, but many real
- INSIDERLarge owner Taiwan Carbon Nano Technology Corp sold $99,806 worth of shares (46,000 units at $2.17), decreasing direct ownership by 4% to 989,925 units (SEC Form 4)4 - Ainos, Inc. (0001014763) (Issuer)
- NEWSAinos to Participate in Fireside Chat with Water Tower Research on January 26, 2026HOUSTON, TEXAS / ACCESS Newswire / January 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Monday, January 26, 2026, at 11:00 a.m. ET.Ainos will discuss its dual-engine SmellTech platform strategy, the strategic benefits of its partnership with Trusval Technology, recent progress in scaling AI Nose technology into commercial deployment, and the Company's strategic priorities for 2026. The event will provide investors with deeper in
- INSIDERLarge owner Taiwan Carbon Nano Technology Corp sold $2,336 worth of shares (1,281 units at $1.82), decreasing direct ownership by 0.12% to 1,035,925 units (SEC Form 4)4 - Ainos, Inc. (0001014763) (Issuer)
- NEWSWater Tower Research Highlights Ainos SmellTech's Rising Commercial Momentum in Scalable AI Infrastructure Platform ShiftAI Nose commercial deployment accelerates in 2026 with dual-engine architecture, industrial expansion, and recurring SaaS revenue modelNew Trusval agreement commits to minimum 600-unit deployment, positioning AI Nose into front-end semiconductor manufacturingHOUSTON, TEXAS / ACCESS Newswire / January 12, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that Water Tower Research ("WTR") has published a report spotlighting the Company's accelerated evolution from SmellTech R&D to large-scale commercial deployment, supported by a scalable AI infrastructu